Tumor-stromal interactions in breast tumor progression - significance of histological heterogeneity of tumor-stromal fibroblasts

被引:18
|
作者
Hasebe, Takahiro [1 ]
机构
[1] Natl Canc Ctr Hosp East, Dept Pathol & Clin Labs, Kashiwa, Chiba 2778577, Japan
基金
日本学术振兴会;
关键词
breast; carcinoma; endothelial cell; fibroblast; fibrotic focus; INVASIVE DUCTAL CARCINOMA; CANCER-ASSOCIATED FIBROBLASTS; HISTOPATHOLOGICAL PROGNOSTIC PARAMETER; EARLY DISTANT RELAPSE; FIBROTIC FOCUS; GROWTH-FACTOR; LYMPH-NODE; UP-REGULATION; INTRATUMORAL FIBROBLASTS; SIGNIFICANT PREDICTORS;
D O I
10.1517/14728222.2013.757305
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Existing pathological diagnostic protocols for breast cancer do not fully reflect the biological characteristics of tumor stromata. To improve the pathological diagnosis of breast cancer, a new pathological diagnostic method capable of assessing the degree of breast cancer malignancy based on the histological features of the tumor stroma is needed. Areas covered: The presence of a fibrotic focus (FF), which consists of fibroblasts or collagen fibers, and the presence of atypical tumor-stromal fibroblasts are significantly associated with nodal metastasis or distant-organ metastasis in patients with invasive ductal carcinoma (IDC) of the breast. FF is the only factor that is significantly associated with an increase in tumor angiogenesis. The importance of FF and atypical tumor-stromal fibroblasts clearly indicates that the malignant potential of IDC does not depend only on the biological characteristics of the tumor cell, but also on those of the tumor stroma. Expert opinion: The biological characteristics of fibroblasts forming an FF or atypical tumor-stromal fibroblasts probably differ from those of fibroblasts located outside an FF or ordinary tumor-stromal fibroblasts. Thus, similar to tumor cells, the heterogeneity of tumor-stromal fibroblasts probably influences the outcome of patients with IDC of the breast.
引用
收藏
页码:449 / 460
页数:12
相关论文
共 50 条
  • [1] Tumor-Stromal Interactions in Medulloblastoma
    Pollack, Ian F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (20): : 1942 - 1943
  • [2] Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression
    Staser, Karl
    Yang, Feng-Chun
    Clapp, D. Wade
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7, 2012, 7 : 469 - 495
  • [3] Tumor-stromal interactions in pancreatic cancer
    Tod, Jo
    Jenei, Veronika
    Thomas, Gareth
    Fine, David
    [J]. PANCREATOLOGY, 2013, 13 (01) : 1 - 7
  • [4] Tumor-stromal interactions in bone metastasis
    Nannuru K.C.
    Singh R.K.
    [J]. Current Osteoporosis Reports, 2010, 8 (2) : 105 - 113
  • [5] Ablation of β-catenin signaling in stromal fibroblasts inhibits dynamic tumor-stromal interactions
    Yang, K.
    Zhou, L.
    Kadekaro, A.
    Zhang, Y.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S143 - S143
  • [6] A Hybrid Model of Tumor-Stromal Interactions in Breast Cancer
    Kim, Yangjin
    Othmer, Hans G.
    [J]. BULLETIN OF MATHEMATICAL BIOLOGY, 2013, 75 (08) : 1304 - 1350
  • [7] Atypical Tumor-stromal Fibroblasts in Invasive Ductal Carcinoma of the Breast
    Hasebe, Takahiro
    Iwasaki, Motoki
    Akashi-Tanaka, Sadako
    Hojo, Takashi
    Shibata, Tatsuhiro
    Sasajima, Yuko
    Kinoshita, Takayuki
    Tsuda, Hitoshi
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (03) : 325 - 336
  • [8] Targeting tumor-stromal interactions in bone metastasis
    Esposito, Mark
    Kang, Yibin
    [J]. PHARMACOLOGY & THERAPEUTICS, 2014, 141 (02) : 222 - 233
  • [9] The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions
    Sidhu, SS
    Mengistab, AT
    Tauscher, AN
    LaVail, J
    Basbaum, C
    [J]. ONCOGENE, 2004, 23 (04) : 956 - 963
  • [10] TUMOR-STROMAL INTERACTIONS IN COLORECTAL CANCER TREATMENT
    Garvey, C.
    Spiller, E.
    Kim, S.
    Mumenthaler, S.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 224 - 224